Advancing the development and implementation of hologenomics in biological sciences
Acronym
HoloGen
Description of the granted funding
Basic biology as well as applied fields such as agrobiology, biomedicine or biotechnology are undergoing a revolution driven by the realisation that microorganisms impact virtually all biological processes. Microorganisms associated with complex organisms are no longer considered passive passengers but active crews that continuously interact with their host to shape a wide range of biological functions that play a key role in major basic and applied processes. The application of the newest high throughput molecular technologies to address such interplay has given rise to the novel field of hologenomics, which entails the joint analysis of host genomes and microbial metagenomes with the aim of understanding the impact of host-microbiota interactions in basic and applied biological processes. The DN HoloGen has been conceived to lead the development and practical implementation of hologenomics in order to gain a more comprehensive understanding of host-microbiota interactions, and their impact in both basic and applied areas with direct relevance to many of the global societal challenges. We propose to form an unprecedented multidisciplinary and scientifically sound training network by bringing together top researchers with theoretical knowledge on symbiosis biology, microbial ecology, animal evolution, animal production and biomedicine, as well as practical expertise in large- scale (meta)genomics, DNA sequence analysis, metabolomics, computational biology and biological systems modelling. We anticipate that the research results will be (i) of academic relevance through development of new analytical frameworks and understandings of host-microbiome interactions, (ii) of direct relevance to the portfolios of the industrial partners, and (iii) through these portfolios stand to benefit the European Research and Innovation community.
Show moreStarting year
2024
End year
2028
Granted funding
Participant
Participant
Aluke Ltd
Participant
AFEKTA TECHNOLOGIES LTD
286 488 €
Participant
CONSORCIO PARA LA EXPLOTACION DEL CENTRO NACIONAL DE ANALISIS GENOMICO (ES)
251 971.2 €
Participant
ZiBA Science Resources SL (ES)
Participant
MYBIOTICS PHARMA LTD (IL)
Participant
GENETIC ANALYSIS AS (NO)
Participant
BIOMIN HOLDING GMBH (AT)
Participant
NORSVIN SA (NO)
Participant
EWOS INNOVATION AS (NO)
Participant
NORGES MILJO-OG BIOVITENSKAPLIGE UNIVERSITET (NO)
893 246.4 €
Coordinator
THE UNIVERSITY OF BIRMINGHAM (UK)
Participant
THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD (UK)
Participant
UNIVERSITAT DE BARCELONA (ES)
Participant
KOBENHAVNS UNIVERSITET (DK)
603 576 €
Participant
KATHOLIEKE UNIVERSITEIT LEUVEN (BE)
262 620 €
Participant
Amount granted
2 870 878 €
Funder
European Union
Funding instrument
HORIZON TMA MSCA Doctoral Networks
Framework programme
Horizon Europe (HORIZON)
Call
Programme part
Marie Skłodowska-Curie Actions (MSCA) (11677Topic
MSCA Doctoral Networks 2023 (HORIZON-MSCA-2023-DN-01-01Call ID
HORIZON-MSCA-2023-DN-01 Other information
Funding decision number
101169005
Identified topics
microbiome, microbiology